Hepatitis B cure: From discovery to regulatory approval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis B cure: From discovery to regulatory approval

Published:2017-08-01 Issue:4 Volume:66 Page:1296-1313
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lok Anna S.¹,Zoulim Fabien²,Dusheiko Geoffrey³,Ghany Marc G.⁴

Affiliation:

1. Division of Gastroenterology and Hepatology; University of Michigan; Ann Arbor MI

2. Cancer Research Center of Lyon-INSERM U1052; Hospices Civils de Lyon, Lyon University; Lyon France

3. University College London Medical School and Kings College Hospital; London UK

4. Liver Diseases Branch; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Bethesda MD

Publisher

Wiley

Subject

Hepatology

Reference86 articles.

1. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

2. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept;Bertoletti;Cell Mol Immunol,2015

3. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B;Kennedy;Gastroenterology,2012

4. Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B;Park;Gastroenterology,2016

5. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood;Wu;Hepatology,2016

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel mechanistic insights – A brand new Era for anti-HBV drugs;European Journal of Medicinal Chemistry;2024-12

2. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2;Journal of Hepatology;2024-09

3. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives;Advanced Drug Delivery Reviews;2024-09

4. Efficacy and safety of therapeutic vaccines for the treatment of chronic hepatitis B: A systematic review and meta-analysis of randomized controlled trials update;Medicine;2024-08-30

5. Challenges in the management of hepatitis B virus;Hepatitis B Virus - Pathogenesis and Therapeutic Approaches [Working Title];2024-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3